Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population
✍ Scribed by Kati Pääkkönen; Sanna Sauramo; Laura Sarantaus; Pia Vahteristo; Anitta Hartikainen; Paula Vehmanen; Jaakko Ignatius; Vesa Ollikainen; Helena Kääriäinen; Erkki Vauramo; Heli Nevanlinna; Ralf Krahe; Kaija Holli; Juha Kere
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 130 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0741-0395
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. There is a clear and growing need for data regarding BRCA1 and BRCA2 mutation frequencies among breast carcinoma cases not specifically ascertained on the basis of extreme family history profiles. Toward this end, the authors previously reported results with regard to BRCA1 in breast
We have investigated the impact of BRACA1 and BRACA2 mutations that were frequently identified among Hungarian high-risk breast-ovarian cancer families (Ramus et al., 1997b, AJHG), on the development of breast and ovarian cancer in the general Hungarian population. The prevalence of 3 BRCA1 mutation
We have developed a 2-stage protocol for BRCA1 and BRCA2 mutation screening from blood spot paper. Stage 1 screening was aimed to analyze patients at highest risk for the most common disease-associated sequence variants listed in the BIC database. Accordingly, stage1 testing implied detection of 18